The goal of this study is to compare whether antihypertensive treatment in the postpartum
period decreases postpartum hypertension and its associated maternal morbidity, including
risk of readmission and healthcare utilization in comparison with no treatment. Women with
preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be
randomized to either initiate antihypertensive treatment or standard of care. We hypothesize
that postpartum antihypertensive treatment of patients with preeclampsia will decrease risk
of hospital readmission, healthcare utilization and the number of severe range blood
pressures at postpartum follow-up visits.